Clinical observations from The Cancer Genome Atlas database showed that elevated IGF2BP2 levels in PCa tissues were significantly associated with higher Gleason scores and exhibited a trend toward correlating with tumor metastasis. This evidence concerns the gene IGF2BP2 and neoplasm.